Advanced search

Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(suppl. 2). p.229-229
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Salles, G, J Catalano, P Feugier, Fritz Offner, R Bouabdallah, D Caballero, P Brice, et al. 2010. “Rituximab Maintenance for 2-years Significantly Improves the Outcome of Patients with Untreated High Tumor Burden Follicular Lymphoma After Response to Immunochemotherapy: Results of the PRIMA Study.” In Haematologica-the Hematology Journal, 95:229–229.
APA
Salles, G, Catalano, J., Feugier, P., Offner, F., Bouabdallah, R., Caballero, D., Brice, P., et al. (2010). Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (Vol. 95, pp. 229–229). Presented at the 15th Annual meeting of the European Hematology Association.
Vancouver
1.
Salles G, Catalano J, Feugier P, Offner F, Bouabdallah R, Caballero D, et al. Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2010. p. 229–229.
MLA
Salles, G, J Catalano, P Feugier, et al. “Rituximab Maintenance for 2-years Significantly Improves the Outcome of Patients with Untreated High Tumor Burden Follicular Lymphoma After Response to Immunochemotherapy: Results of the PRIMA Study.” Haematologica-the Hematology Journal. Vol. 95. 2010. 229–229. Print.
@inproceedings{2119653,
  author       = {Salles, G and Catalano, J and Feugier, P and Offner, Fritz and Bouabdallah, R and Caballero, D and Brice, P and Pedersen, LM and Haioun, C and Belada, D and Delmer, A and Simpson, D and Tilly, H and Leppa, S and Soubeyran, P and Hagenbeek, A and Casasnovas, O and Tanin, I and Ferme, C and Da Silva, MG and Sebban, C and Pettengell, R and Estell, J and Milone, G and Sonnet, A and Lopez-Guillermo, A and Seymour, J and Xerri, L},
  booktitle    = {HAEMATOLOGICA-THE HEMATOLOGY JOURNAL},
  issn         = {0390-6078},
  language     = {eng},
  location     = {Barcelona, Spain},
  number       = {suppl. 2},
  pages        = {229--229},
  title        = {Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study},
  volume       = {95},
  year         = {2010},
}

Web of Science
Times cited: